World Conference on COPD Patients

Slides:



Advertisements
Similar presentations
GOLD MANAGEMENT PLAN FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Advertisements

Optimizing the Management of Chronic Obstructive Pulmonary Disease (COPD) Note to the Speaker: All bold underlined statements must be read aloud to the.
Academy Board Prep PCCM
Michael W. Nash, MD Family Medicine Clinton County Rural Health Clinic Understanding COPD.
Frequency of self-reported COPD exacerbation and airflow obstruction in five Latin American cities: the PLATINO study M. Montes de Oca 1, C. Talamo 1,
Basma Y. Kentab MSc. Department of Clinical Pharmacy May 2014.
Prevalence of smoking in Saudi Arabia Yousef Abdullah Al Turki MBBS,DPHC,ABFM Associate Professor Family Medicine College of Medicine King Saud University.
PRESS Conference D. Galdermans: global information J. Buffels: what is spirometry? G. Joos: GOLD guidelines in COPD G. de Bilderling and R. Louis: GINA.
Criner et al. NEJM 2014: 370; 23 Simvastatin for the Prevention of Exacerbations in Moderate-to-Severe COPD (STATCOPE) Presented by Ali Naqvi, MD.
COPD Patients‘ Bill of Rights Jochen Scheld. The Bill of Rights.
Practice Support Program in COPD: South Okanagan Project COPD CARE Algorithm South Okanagan, Interior Health Patricia Rattee RRT, CRE Shannon Walker MD,
COPD Patients' Unmet Needs: The Japanese Experience First World Conference of COPD Patients Jun 14, 2009 (Rome, Italy) Yuma Hoshino MD, PhD and Michiaki.
Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.
THE DAY OF SPIROMETRY BVP-SBP Dr Galdermans ZNA Middelheim Hospital Antwerp.
© 2013 Global Initiative for Chronic Obstructive Lung Disease
Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)
Chronic Obstructive Pulmonary Disease
Latin American Society of Psoriasis -SOLAPSO- President: Prof. Edgardo Chouela MD, PhD General Secretary: Javier Ubogui MD PSORIASIS 2010 CONGRESS OF THE.
Demonstration of a Process- Outcome Link for Smoking Cessation Melissa M. Farmer, PhD 1,2 Elizabeth M. Yano, PhD 1,2 Brian S. Mittman, PhD 1,2 Scott E.
 Smoking is the primary cause of avoidable death  Thousand of teens try cigarettes daily.  Smoking contributes to an astonishing number of diseases.
The National Lung Health Education Program Programs for the Respiratory Therapist.
Cancer Healthy Kansans 2010 Steering Committee Meeting May 12, 2005.
The Center for Health Systems Transformation
Dr. Corinne Husten Director (Acting), Office on Smoking and Health The Global Tobacco Epidemic.
GOLD Update 2011 Rabab A. El Wahsh, MD. Lecturer of Chest Diseases and Tuberculosis Minoufiya University REVISED 2011.
Smoking Bans in Prisons: The Final Frontier Karen L. Cropsey, Psy.D. Assistant Professor Virginia Commonwealth University.
Asthma A Presentation on Asthma Management and Prevention.
My conflicts of interest during the last two years GSK has supported my participation in ERS congress 2010 Utrecht, September the 23th 2011.
Presenting Organization Event Name Event Date Presenter Name, Title COPD Essentials for Physicians
The Negative Impact of Air pollution on Respiratory Health Dr Des Murphy Consultant Respiratory Physician CUH.
Enhancing Tobacco Cessation Treatment for the Medicaid Population Linda Bailey, Center for Tobacco Cessation Helen Halpin, University of California at.
Respiratory disease programme for Darlington : a catalyst for change. Dr Basil Penney Sr. Claire Adams Darlington CCG Respiratory Leads.
Chronic Kidney Disease (CKD) Healthy Kansans 2010.
Disparities in Health and Treatment Seniors who belong to more than one group at risk for lower socioeconomic status are at increased risk for illness.
Increased Risk of Exacerbation and Hospitalization in Subjects With an Overlap Phenotype (COPD-Asthma) Ana Maria B. Menezes, MD ; Maria Montes de Oca,
1 ECPC PAPER ON BLADDER CANCER FRANCESCO DE LORENZO Brussels, 20 April 2016.
1. Identify patients in our practice with a diagnosis of asthma or presumed asthma who have not had formal pulmonary function testing or in house spirometry.
COPD Local Burden The Philippines. COPD A Global Health Concern COPD a growing cause of morbidity & mortality worldwide 5 th leading cause of death (2002)
Spirometry tests were carried out by a Respiratory Clinical Nurse Specialist (Respiratory CNS) Participants were referred to see their General Practitioner.
1 Study on the Coverage of Chronic Diseases in Social and Health Protection Systems: A Comparative Analysis of Trends in Developed Countries and in the.
Providing Leadership, Promoting Quality, and Taking Action. Partnering for Health Promotion: A collaboration between state tobacco cessation and diabetes.
The Impact of Smoking Cessation Interventions by Multiple Health Professionals Lawrence An, MD 1 ; Steven Foldes, PhD 2 ; Nina Alesci, PhD 1 ; Patricia.
Research where it is most needed National Respiratory Strategy
A Survey of Knowledge, Attitudes and Practices of Doctors in General Practice in Singapore Towards Chronic Obstructive Pulmonary Disease Dr David Cheong,
BRONCHIAL ASTHMA YOUSEF ABDULLAH AL TURKI MBBS,DPHC,ABFM
Patti Olusola, M.D. Kathryn Wortz, Ph.D. Robert B. Tompkins, M.D.
Jane E Scullion Respiratory Nurse Consultant
Asthma-COPD Overlap Syndrome (ACOS) Challenges Diagnosing ACOS
EFA Book on COPD in Europe
Assessing COPD in Primary Care
COPD.
Starting Strong: Initial Evaluation of the Patient With HCV
Differences in awareness, treatment, and control of hypertension between Southerners and non-Southerners Hypertension awareness, treatment, and control.
Community Health Pearl:
LATE DIAGNOSIS – IS IT A PROBLEM?
A pragmatic stepped intervention cluster randomized trial
National COPD Audit Programme
Sundeep Salvi, MD, DNB, PhD, FCCP, Peter J. Barnes, DM, FCCP  CHEST 
IoT adoption strategy in a hospital environment
Nurses making a difference in tobacco dependence treatment in Portugal
Diagnosi della BPCO 1.
Relative risks of clinical events for primary and secondary prevention with selected drugs Thomas A Gaziano, et al. Lancet 2006; 368:
Dr Vincent NINANE – CHU Saint-Pierre
Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.
Cardiovascular Disease in Women Module IX: Presentation Resources and Internet Resources This slide set was updated April 2008.
The Heart Truth Delaware Background
Thank you for viewing this presentation.
Health profile used in workshops to help people make diabetes management decisions. Health profile used in workshops to help people make diabetes management.
Screening test accuracy of the final risk score at a threshold of ≥2
Agenda. Diagnosis, Assessment, and Treatment of the COPD Patient in Primary Care.
Presentation transcript:

World Conference on COPD Patients María Victorina López Varela University of Montevideo Hospital Maciel Uruguay Rome, June 2009

Cross-sectional multi-site study COPD: The Latin American Perspective PROYECTO LATINOAMERICANO DE INVESTIGACION EN OBSTRUCCION PULMONAR http://www.platino-alat.org Brasil Chile Venezuela México Uruguay PLATINO Menezes Lancet 2005; 366:1875 Colombia PREPOCOL Chest 2008; 133:343 Cross-sectional multi-site study 5 LA cities Population-based Adults ≥ 40 years old 5571questionnaires 5315 spirometries post BD 758 COPD

COPD: The Latin American Perspective Prevalent

COPD: The Latin American Perspective Risk factors : smoking biomass exposure

COPD: The Latin American Perspective Under and misdiagnosed

COPD: The Latin American Perspective Under and anaccurate treated

COPD: The Latin American Perspective Frequent exacerbations Montes de Oca M. et al Chest online Un n ú Exacerbations are frequent in COPD patients and related to severity

COPD: The Latin American Perspective Underuse of spirometry

COPD: The Latin American Perspective What are we doing ? ALAT Educational programs / Courses : Primary care Pulmonologists Awareness : Campaigns exist Patients Associations are growing

Smoking bans and cessation programs

Conference Summary & Global Mandate GOALS Presenting take-home-messages from workshops Initiating new campaigns on Increasing awareness (diagnosis, disease, treatment) Smoking as a major cause Smoking bans in public Introducing the four letter abbreviation COPD to the public White Paper: Summarizing the findings of this congress and further actions,

Conference Summary & Global Mandate AWARENESS Should be first step to fight COPD Is low among public and physicians in most regions of the world Public campaigns and events to inform about COPD have been successfully performed Must be globally improved by government, health-care givers, patient organizations,

Conference Summary & Global Mandate SMOKING PREVENTION “Tobacco smoking is linked to COPD” Tobacco smoking is one major cause to develop COPD Anti-smoking-campaigns and smoking bans are needed to fight COPD There are wide regions globally where smoking is increasing and not banned Public smoking bans can positive influence smokers habit Smoking cessation can be achieved

Conference Summary & Global Mandate DIAGNOSIS AND TREATMENT Regions with: Lack of diagnosis Lack of availability or unaffordability of treatment Prevention of COPD and screening measures to better diagnose disease should be emphasized Treatment has to be provided by government in areas, where medication is not available or too expensive for patients.